Cairo – Mubasher: Egypt’s Financial Regulatory Authority has approved October Pharma’s capital increase disclosure, according to a bourse statement released on Thursday.
The company’s issued, paid-up, and authorised capital will be increased to EGP 120 million from EGP 60 million.
It is worth highlighting that during the first half of 2019, October Pharma’s profits shrank to EGP 3.33 million from EGP 9.99 million during H1-18.
